The present invention relates to novel hydroxamic acids which are specific histone deacetylase (HDAC) inhibitors and/or TTK/Mpsl kinase inhibitors, including pharmaceutically acceptable salts thereof, which are useful for modulating HDAC and/or TTK/Mpsl kinase activity, pharmaceutical compositions comprising these compounds, and processes for their preparation.
本发明涉及一种新型的羟羧胺酸,它们是特异的组蛋白
去乙酰化酶(H
DAC)
抑制剂和/或
TTK/Mps1激酶
抑制剂,包括其药用盐,用于调节H
DAC和/或
TTK/Mps1激酶活性,包括这些化合物的制药组合物,以及其制备方法。